234 related articles for article (PubMed ID: 19841149)
1. Pharmacokinetics of artemether-lumefantrine and artesunate-amodiaquine in children in Kampala, Uganda.
Mwesigwa J; Parikh S; McGee B; German P; Drysdale T; Kalyango JN; Clark TD; Dorsey G; Lindegardh N; Annerberg A; Rosenthal PJ; Kamya MR; Aweeka F
Antimicrob Agents Chemother; 2010 Jan; 54(1):52-9. PubMed ID: 19841149
[TBL] [Abstract][Full Text] [Related]
2. Population pharmacokinetics of artesunate and amodiaquine in African children.
Stepniewska K; Taylor W; Sirima SB; Ouedraogo EB; Ouedraogo A; Gansané A; Simpson JA; Morgan CC; White NJ; Kiechel JR
Malar J; 2009 Aug; 8():200. PubMed ID: 19691851
[TBL] [Abstract][Full Text] [Related]
3. Comparative oral bioavailability of non-fixed and fixed combinations of artesunate and amodiaquine in healthy Indian male volunteers.
Fortin A; Verbeeck RK; Jansen FH
Eur J Clin Pharmacol; 2011 Mar; 67(3):267-75. PubMed ID: 20949263
[TBL] [Abstract][Full Text] [Related]
4. Significant pharmacokinetic interactions between artemether/lumefantrine and efavirenz or nevirapine in HIV-infected Ugandan adults.
Byakika-Kibwika P; Lamorde M; Mayito J; Nabukeera L; Namakula R; Mayanja-Kizza H; Katabira E; Ntale M; Pakker N; Ryan M; Hanpithakpong W; Tarning J; Lindegardh N; de Vries PJ; Khoo S; Back D; Merry C
J Antimicrob Chemother; 2012 Sep; 67(9):2213-21. PubMed ID: 22687893
[TBL] [Abstract][Full Text] [Related]
5. Pyronaridine-artesunate or dihydroartemisinin-piperaquine versus current first-line therapies for repeated treatment of uncomplicated malaria: a randomised, multicentre, open-label, longitudinal, controlled, phase 3b/4 trial.
West African Network for Clinical Trials of Antimalarial Drugs (WANECAM)
Lancet; 2018 Apr; 391(10128):1378-1390. PubMed ID: 29606364
[TBL] [Abstract][Full Text] [Related]
6. Population pharmacokinetics of artemether, lumefantrine, and their respective metabolites in Papua New Guinean children with uncomplicated malaria.
Salman S; Page-Sharp M; Griffin S; Kose K; Siba PM; Ilett KF; Mueller I; Davis TM
Antimicrob Agents Chemother; 2011 Nov; 55(11):5306-13. PubMed ID: 21876056
[TBL] [Abstract][Full Text] [Related]
7. Validation and pharmacokinetic application of a high-performance liquid chromatographic technique for determining the concentrations of amodiaquine and its metabolite in plasma of patients treated with oral fixed-dose amodiaquine-artesunate combination in areas of malaria endemicity.
Adedeji ON; Bolaji OO; Falade CO; Osonuga OA; Ademowo OG
Antimicrob Agents Chemother; 2015 Sep; 59(9):5114-22. PubMed ID: 25896711
[TBL] [Abstract][Full Text] [Related]
8. Pharmacokinetic Interactions between Tafenoquine and Dihydroartemisinin-Piperaquine or Artemether-Lumefantrine in Healthy Adult Subjects.
Green JA; Mohamed K; Goyal N; Bouhired S; Hussaini A; Jones SW; Koh GC; Kostov I; Taylor M; Wolstenholm A; Duparc S
Antimicrob Agents Chemother; 2016 Dec; 60(12):7321-7332. PubMed ID: 27697758
[TBL] [Abstract][Full Text] [Related]
9. Concomitant nevirapine impacts pharmacokinetic exposure to the antimalarial artemether-lumefantrine in African children.
Huang L; Carey V; Lindsey JC; Marzan F; Gingrich D; Graham B; Barlow-Mosha L; Ssemambo PK; Kamthunzi P; Nachman S; Parikh S; Aweeka FT;
PLoS One; 2017; 12(10):e0186589. PubMed ID: 29065172
[TBL] [Abstract][Full Text] [Related]
10. Concomitant efavirenz reduces pharmacokinetic exposure to the antimalarial drug artemether-lumefantrine in healthy volunteers.
Huang L; Parikh S; Rosenthal PJ; Lizak P; Marzan F; Dorsey G; Havlir D; Aweeka FT
J Acquir Immune Defic Syndr; 2012 Nov; 61(3):310-6. PubMed ID: 22918158
[TBL] [Abstract][Full Text] [Related]
11. Lopinavir/ritonavir affects pharmacokinetic exposure of artemether/lumefantrine in HIV-uninfected healthy volunteers.
German P; Parikh S; Lawrence J; Dorsey G; Rosenthal PJ; Havlir D; Charlebois E; Hanpithakpong W; Lindegardh N; Aweeka FT
J Acquir Immune Defic Syndr; 2009 Aug; 51(4):424-9. PubMed ID: 19506482
[TBL] [Abstract][Full Text] [Related]
12. Safety and tolerability of combination antimalarial therapies for uncomplicated falciparum malaria in Ugandan children.
Maiteki-Sebuguzi C; Jagannathan P; Yau VM; Clark TD; Njama-Meya D; Nzarubara B; Talisuna AO; Kamya MR; Rosenthal PJ; Dorsey G; Staedke SG
Malar J; 2008 Jun; 7():106. PubMed ID: 18547415
[TBL] [Abstract][Full Text] [Related]
13. Electrocardiographic study in Ghanaian children with uncomplicated malaria, treated with artesunate-amodiaquine or artemether-lumefantrine.
Adjei GO; Oduro-Boatey C; Rodrigues OP; Hoegberg LC; Alifrangis M; Kurtzhals JA; Goka BQ
Malar J; 2012 Dec; 11():420. PubMed ID: 23244570
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetic and pharmacodynamic characteristics of a new pediatric formulation of artemether-lumefantrine in African children with uncomplicated Plasmodium falciparum malaria.
Djimdé AA; Tekete M; Abdulla S; Lyimo J; Bassat Q; Mandomando I; Lefèvre G; Borrmann S;
Antimicrob Agents Chemother; 2011 Sep; 55(9):3994-9. PubMed ID: 21670177
[TBL] [Abstract][Full Text] [Related]
15. Therapeutic efficacy of artesunate-amodiaquine combinations and the plasma and saliva concentrations of desethylamodiaquine in children with acute uncomplicated Plasmodium falciparum malaria.
Sowunmi A; Gbotosho GO; Happi CT; Okuboyejo TM; Sijuade AO; Michael OS; Adewoye EO; Folarin O
Am J Ther; 2013 Jan; 20(1):48-56. PubMed ID: 21192244
[TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics and electrocardiographic pharmacodynamics of artemether-lumefantrine (Riamet) with concomitant administration of ketoconazole in healthy subjects.
Lefèvre G; Carpenter P; Souppart C; Schmidli H; McClean M; Stypinski D
Br J Clin Pharmacol; 2002 Nov; 54(5):485-92. PubMed ID: 12445027
[TBL] [Abstract][Full Text] [Related]
17. Drug Interactions between Dolutegravir and Artemether-Lumefantrine or Artesunate-Amodiaquine.
Walimbwa SI; Lamorde M; Waitt C; Kaboggoza J; Else L; Byakika-Kibwika P; Amara A; Gini J; Winterberg M; Chiong J; Tarning J; Khoo SH
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30420479
[TBL] [Abstract][Full Text] [Related]
18. Population Pharmacokinetics and Pharmacodynamics of Lumefantrine in Young Ugandan Children Treated With Artemether-Lumefantrine for Uncomplicated Malaria.
Tchaparian E; Sambol NC; Arinaitwe E; McCormack SA; Bigira V; Wanzira H; Muhindo M; Creek DJ; Sukumar N; Blessborn D; Tappero JW; Kakuru A; Bergqvist Y; Aweeka FT; Parikh S
J Infect Dis; 2016 Oct; 214(8):1243-51. PubMed ID: 27471317
[TBL] [Abstract][Full Text] [Related]
19. Antiretroviral Choice for HIV Impacts Antimalarial Exposure and Treatment Outcomes in Ugandan Children.
Parikh S; Kajubi R; Huang L; Ssebuliba J; Kiconco S; Gao Q; Li F; Were M; Kakuru A; Achan J; Mwebaza N; Aweeka FT
Clin Infect Dis; 2016 Aug; 63(3):414-22. PubMed ID: 27143666
[TBL] [Abstract][Full Text] [Related]
20. An open label, randomised trial of artesunate+amodiaquine, artesunate+chlorproguanil-dapsone and artemether-lumefantrine for the treatment of uncomplicated malaria.
Owusu-Agyei S; Asante KP; Owusu R; Adjuik M; Amenga-Etego S; Dosoo DK; Gyapong J; Greenwood B; Chandramohan D
PLoS One; 2008 Jun; 3(6):e2530. PubMed ID: 18575626
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
